News

Becker's Hospital Review23h
6 drugs in shortage
Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.
60 Degrees Pharmaceuticals Defines Potential Human Babesiosis Market Size for ARAKODA (tafenoquine): Annual Max TAM, Sales of $245 Million; Cumulative through Patent Expiration ...
New Drug Application intended for 2026, subject to generation of positive data from three U.S. clinical trials planned or in progressTotal addressable market (TAM) for ARAKODA for Human Babesiosis is ...
Taiwan News23h
60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025
Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis; WASHINGTON, July 14, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmace ...